| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 159.62M | 166.46M | 155.02M | 162.15M | 107.57M | 76.57M |
| Gross Profit | 60.24M | 63.47M | 59.75M | 22.93M | 42.63M | 28.48M |
| EBITDA | 10.95M | 8.14M | -20.36M | 14.86M | 5.14M | 3.46M |
| Net Income | -28.48M | -4.46M | -25.33M | 1.89M | 1.70M | 1.88M |
Balance Sheet | ||||||
| Total Assets | 199.03M | 195.63M | 188.00M | 229.04M | 206.78M | 99.38M |
| Cash, Cash Equivalents and Short-Term Investments | 10.44M | 11.85M | 11.24M | 11.04M | 13.16M | 51.72M |
| Total Debt | 55.94M | 55.49M | 56.16M | 61.30M | 66.18M | 17.02M |
| Total Liabilities | 93.36M | 90.01M | 85.15M | 99.51M | 90.27M | 33.30M |
| Stockholders Equity | 105.67M | 105.62M | 102.85M | 129.53M | 116.51M | 66.08M |
Cash Flow | ||||||
| Free Cash Flow | 8.43M | 6.74M | 6.43M | 998.00K | -1.28M | 8.34M |
| Operating Cash Flow | 11.95M | 10.83M | 9.47M | 9.55M | 2.13M | 9.45M |
| Investing Cash Flow | -3.52M | -4.09M | -3.04M | -8.55M | -116.38M | 402.00K |
| Financing Cash Flow | -9.99M | -5.64M | -6.40M | -3.36M | 74.69M | 36.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | AU$164.89M | 26.99 | 12.35% | ― | 39.98% | -30.04% | |
64 Neutral | AU$105.20M | 15.29 | 27.24% | 1.60% | 0.65% | -9.90% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | AU$119.74M | -26.79 | -4.28% | ― | 7.38% | 82.39% | |
41 Neutral | AU$70.02M | -5.38 | -31.98% | ― | 34.20% | -23.90% | |
40 Underperform | AU$84.39M | -11.89 | ― | ― | ― | ― | |
40 Underperform | AU$106.68M | -13.09 | -47.98% | ― | 700.00% | 26.88% |
Trajan Group Holdings Ltd has announced the resignation of Sara Watts from its board of directors, effective October 28, 2025. This change in leadership may influence the company’s strategic direction and stakeholder relations, as Watts held significant shares both personally and through JESET Pty Ltd, indicating a notable shift in the company’s governance structure.
The most recent analyst rating on (AU:TRJ) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
Trajan Group Holdings Limited held its 2025 Annual General Meeting, where all resolutions presented to shareholders were carried with significant majorities. The resolutions included the adoption of the remuneration report and the granting of options to directors, reflecting strong shareholder support for the company’s strategic direction and governance. This outcome reinforces Trajan’s stable position in the analytical science industry and indicates continued confidence from its stakeholders.
The most recent analyst rating on (AU:TRJ) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
Trajan Group Holdings Ltd reported a strong financial performance with a revenue of $166.5 million, reflecting a growth of over 7% despite economic and political uncertainties. The company’s strategic focus on quality and regional manufacturing allowed it to quickly adapt to challenges, launching new product lines in Malaysia within eight weeks. Trajan also emphasized its commitment to sustainability, achieving a ‘good’ EcoVadis sustainability score and transitioning to renewable energy in key regions. The company aims to build long-term value through commercial success and transparent shareholder communication.
The most recent analyst rating on (AU:TRJ) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
Trajan Group Holdings Ltd has announced the issuance of 667,500 unquoted equity securities under an employee incentive scheme, which are subject to transfer restrictions and will not be quoted on the ASX until these restrictions are lifted. This move is part of the company’s strategy to incentivize employees, potentially impacting its operational dynamics by aligning employee interests with company performance, although it does not have immediate implications for external stakeholders.
The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.25 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
Trajan Group Holdings Limited has announced its Annual General Meeting scheduled for October 28, 2025. This meeting will be held online and is a significant event for shareholders, as it will include the presentation of key documents such as the Notice of Annual General Meeting and a Sample Proxy Form. This announcement underscores Trajan’s commitment to maintaining transparency and engagement with its stakeholders, reflecting its strategic focus on expanding its influence in the analytical and life sciences industry.
The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.25 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
Trajan Group Holdings Ltd announced a change in the interest of its director, Sara Watts, who has converted 82,493 unlisted options into ordinary shares under the company’s Long Term Incentive Plan. This change increases her direct holding to 141,257 ordinary shares, reflecting a strategic move to align with the company’s growth objectives and potentially enhance shareholder value.
The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.25 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
Trajan Group Holdings Ltd has announced a change in the director’s interest notice, specifically concerning John Eales. The update details the acquisition of 79,533 ordinary shares and the disposal of an equal number of unlisted options. This change reflects an increase in direct shareholding for John Eales, which may indicate a strategic move to consolidate his position within the company.
The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.25 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
Trajan Group Holdings Ltd has announced the issuance of 162,026 ordinary fully paid shares without disclosure under Part 6D.2 of the Corporations Act. The company has complied with relevant provisions of the Corporations Act and confirmed there is no excluded information required to be disclosed. This issuance is part of Trajan’s ongoing efforts to support its growth and operations in the analytical and life sciences industry.
The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.25 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
Trajan Group Holdings Ltd has announced the quotation of 162,026 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code TRJ. This move is part of the company’s strategy to enhance its market presence and provide liquidity to its shareholders, potentially impacting its operational dynamics and stakeholder engagement.
The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.25 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
Trajan Group Holdings Limited announced that Sara Watts, Non-executive Director and Chair of the Audit and Risk Committee, will retire from the Board and not seek re-election at the 2025 Annual General Meeting. Her departure marks the end of her tenure since joining the Board in March 2021, just before the company’s IPO. Tiffiny Lewin will take over as Chair of the Audit and Risk Committee. This change in leadership may impact the company’s governance and strategic direction as it continues to focus on using science and medical technology to improve human wellbeing.
The most recent analyst rating on (AU:TRJ) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
Trajan Group Holdings Ltd has released its corporate governance statement for the financial year ending June 30, 2025, which is available on their website. The statement confirms that the company has adhered to the ASX Corporate Governance Council’s principles and recommendations, ensuring transparency and accountability in its management and oversight practices.
The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.45 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
Trajan Group Holdings Ltd is a leader in high precision products and services, offering a range of components, consumables, and capital equipment across various sectors. The company’s latest announcement highlights its commitment to innovation through disruptive technologies, aiming to enhance its market position and provide advanced solutions for stakeholders in biological, food, and environmental industries.
The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.45 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.
Trajan Group Holdings Limited announced it will release its Full Year Results for the Financial Year ending June 30, 2025, on August 28, 2025. A live webcast and Q&A session will be hosted by the company’s CEO and CFO, allowing investors to engage and submit questions. This announcement is part of Trajan’s ongoing efforts to maintain transparency and engage with its stakeholders, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.20 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.